Clinical responses* of tacrolimus in the open label extension study at week 10 (No of patients (%))
| High trough group | Low trough group | Placebo group† | Total | |
|---|---|---|---|---|
| *Complete was defined as a complete response, all assessment disease activity index (DAI) scores were zero; partial, a partial response, a reduction in DAI of more than 4 points with improvement of all categories, but not a complete response; and none, no response, other than the above. | ||||
| †Patients who received placebo in the two week double blind study | ||||
| n = 58 | 19 | 20 | 19 | 58 |
| Complete | 1 (5.3) | 1 (5.0) | 1 (5.3) | 3 (5.2) |
| Partial | 10 (52.6) | 9 (45.0) | 10 (52.6) | 29 (50.0) |
| None | 8 (42.1) | 10 (50.0) | 8 (42.1) | 26 (44.8) |